Effectiveness of a 23-valent Polysaccharide Vaccine in Preventing Pneumonia and Non-invasive Pneumococcal Infection in Elderly People: a Large-scale Retrospective Cohort Study

Author： Ansaldi F   Turello V   Lai P   Bastone G   DeLuca S   Rosselli R   Durando P   Sticchi L   Gasparini R   Delfino E   Icardi G  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.33, Iss.5, 2005-09, pp. : 490-500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed): In Older Adults

By Sanford Mark  

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1243-1255

Adis International

Access to resources Recommend Favorite

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]

By Duggan Sean T.  

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 1973-1986

Adis International

Access to resources Recommend Favorite

Pneumococcal vaccine conjugate PPV 23: Lack of efficacy in pneumonia prevention in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1397, 2012-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

The use of HAART and 23-valent conjugated pneumococcal vaccine may reduce the incidence of pneumococcal infections

By  

Inpharma, Vol. 1, Iss. 1502, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Pneumococcal Disease in the Elderly: What is Preventing Vaccine Efficacy?

By Rubins J.B.  

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite